The Council for Entrepreneurial Development (CED) has selected ten North Carolina biotechnology companies to present at its 25th Annual Venture Conference scheduled for April 14-16 in Durham.
These companies will be among 36 early and late stage firms presenting at the conference that is designed to showcase the Southeast and Mid-Atlantic’s top investment opportunities to hundreds of venture capitalists and financiers from throughout the United States.
The North Carolina-based companies include Phase Bioscience, Inc., which has received a total of $240,000 in loans from the NC Biotechnology Center, and Argos Therapeutics, Inc., which has received a $10,000 loan.
NC Companies Presenting:
